Logo

Vineet Laboratories Share Price

NSE: VINEETLAB
|
Pharmaceuticals
₹ 33.45
-₹0.17 (-0.51%)
1D
Last updated 03 Jul, 2026, 15:29 IST

Vineet Laboratories Share Price Today

As of 5 Jul 2026, Vineet Laboratories share price is ₹33.45. The stock opened at ₹34.25, compared to its previous close of ₹33.62. During today's trading session, Vineet Laboratories share price moved in the range of ₹33.10 to ₹34.25, with an average price of ₹33.67 for the day. Looking at its last 52-week, the stock has touched a low of ₹27.96 and a high of ₹49.99. On the performance front, Vineet Laboratories share price has declined by 2.21% over the last six months and is up 1.54% on a year-on-year basis.


₹33.10
0.51% down today
₹34.25
1D LOW
1D HIGH

Vineet Laboratories Returns Calculator

Open
₹34.25
High
₹34.25
Low
₹33.10
Prev. close
₹33.62

Circuit
L
H
₹31.97
₹35.33
52-week
L
H
₹27.96
₹49.99

Vineet Laboratories Shareholder Returns

Vineet Laboratories Share Price History

Mkt Cap Cr
64.15

P/E
-6.33

P/B
1.45

ROE
-117.41%

D/E
3.01

ROCE
-22.41%

Div. Yield
0.00%

EPS(TTM)
-21.90
Turnover
0.60

EV/EBITDA
-29.45

Net Margin
-26.92%

Op. Margin
-19.05%

ROA
-11.20%

Quick Ratio
0.23

Curr. Ratio
2.05
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Vineet Laborator has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Vineet Laborator appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Vineet Laboratories Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹75.00₹150.59₹212.29₹191.17
Other Income₹1.99₹0.46₹0.12₹0.29
Total Revenue₹76.98₹151.05₹212.42₹191.46
Total Expenses₹97.76₹150.69₹210.39₹182.11
Profit Before Tax-₹20.78₹0.36₹2.03₹9.35
Tax-₹0.58-₹0.66₹0.78₹2.71
Profit After Tax-₹20.19₹1.03₹1.25₹6.64
EPS - Basic-₹21.90₹1.11₹1.36₹7.16
EPS - Diluted-₹21.90₹1.11₹1.36₹7.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹20.78₹0.36₹2.03₹9.35
Income before WC changes-₹12.34₹7.15₹8.00₹13.25
Change in Assets₹21.13-₹1.21₹5.87-₹7.16
Change in Liabilities₹2.82-₹12.29-₹20.50₹4.72
Change in WC₹23.95-₹13.50-₹14.63-₹2.43
Cash flow from Operations₹11.49-₹6.61-₹9.62₹7.63
Cash flow from Investing-₹3.18-₹2.22-₹6.69-₹3.68
Cash flow from Financing-₹8.23₹8.43₹0.27₹11.96
Total Cash Flow₹0.08-₹0.40-₹16.03₹15.91
Cash (Start of the year)₹0.23₹0.63₹16.66₹0.75
Cash (End of the year)₹0.31₹0.23₹0.63₹16.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹27.15₹28.68₹28.39₹30.61
Current Assets₹67.39₹88.19₹87.46₹102.70
Total Assets₹94.54₹116.87₹115.85₹133.32
Current Liabilities₹74.39₹76.00₹74.51₹94.77
Net Current Asset-₹7.00₹12.19₹12.95₹7.94
Non-Current Liabilities₹5.50₹6.15₹7.66₹5.33
Equity Capital₹14.65₹34.72₹33.68₹33.22
Total Equity & Liabilities₹94.54₹116.87₹115.85₹133.32
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
45.48
Neutral

ATR (14)
1.31
Neutral

STOCH(9,6)
46
Neutral

STOCH RSI (14)
31.9
Neutral

ADX(9)
27.82
Bearish

UO(9)
47.24
Neutral

ROC(12)
-3.42
Bearish

WillR(14)
-65.05
Neutral
Period
Simple value
Exponential vaue

5D
33.54
33.65

10D
33.89
33.83

20D
34.08
34.11

50D
35.52
34.37

100D
33.32
34.73

About Vineet Laboratories

Vineet Laboratories logo
ISIN
INE505Y01010
Sector Market Cap
₹ 64.15 Cr

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Know more
Promoters
5.98%
FII
0.36%
Other DII
0.00%
Retail and other
93.66%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Vineet Laboratories logo
Vineet Laboratories
Pharmaceuticals
Add Stock
Add Another

FAQs on Vineet Laboratories Share Price